Stoop 2011.

Trial name or title	Disease management for comorbid depression and anxiety in diabetes mellitus: design of a randomised controlled trial in primary care
Methods	Randomised controlled trial
Participants	Type 2 diabetes mellitus patients, aged 18 or over and with elevated depressive (PHQ‐9 score 7 or more) and/or anxiety symptoms (GAD‐7 score 8 or more). Patients are excluded if they currently receive psychological treatment for their symptoms of depression or anxiety, experience major psychiatric problems, such as schizophrenia and suicidal ideation, are addicted to alcohol, drugs or gambling, are cognitively impaired, or are unable to read or speak Dutch sufficiently
Interventions	Intervention: DiMaCoDeA‐DM2 (disease management intervention for comorbid depression and anxiety in patients with DM2) ‐ active screening, stepped care treatment and monitoring of depression/anxiety Control: Care as usual
Outcomes	Depression and anxiety (PHQ‐9 and GAD‐7). Secondary outcomes: Quality of life, health status, diabetes specific distress, self‐management, medication adherence and cost‐effectiveness
Starting date	January 2011, end December 2013
Contact information	Francois Pouwer f.pouwer@uvt.nl
Notes	GAD: generalised anxiety disorder; PHQ‐9: Patient Health Questionnaire‐9; DM: diabetes mellitus